ELOXX PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Two Years
ELOXX PHARMACEUTICALS, INC. (ELOX) had Operating Leases, Future Minimum Payments, Due in Two Years of $490.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-03-06
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $490.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $232.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $490.00K 10-K · filed 2020-03-06 |
| 2017-12-31 | $232.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |